Pfizer Inc.'s Crizotinib Wipes Out Rare Lymphoma in Two Test Cases

Bloomberg -- Pfizer Inc.’s experimental drug to treat a type of lung cancer appeared to wipe out a rare form of lymphoma in two severely ill patients in test cases reported by doctors.

MORE ON THIS TOPIC